Mechanistically, we demonstrated that celastrol-induced cellular proliferation inhibition and apoptosis in pancreatic cancer cells by downregulating Claspin and Bcl-2 expression in an m6A-YTHDF3-mediated manner. Here, BCL2 is linked to pancreatic neoplasm.